Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Last Updated: January 19, 2020

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for ciclopirox

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Bulk Pharmaceutical API Sources for ciclopirox

Vendor Vendor Homepage Vendor Sku API Url
Hangzhou Trylead Chemical Technology   Start Trial TL8002303   Start Trial
NovoSeek   Start Trial 2749   Start Trial
ISpharm   Start Trial I06-0862   Start Trial
MolPort   Start Trial MolPort-003-845-943   Start Trial
ABI Chem   Start Trial AC1L1EDN   Start Trial
ChemMol   Start Trial 30102673   Start Trial
ChemMol   Start Trial 44002178   Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.